Marketing Manager, Cochlear Americas
Cochlear Partners with Everseat to Provide Mobile Scheduling App to Cochlear Clinic Partners
Centennial, Colo., (January 14, 2015) – Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today that it has entered into a multi-year agreement with the rapidly growing technology startup, Everseat, to provide an all new mobile scheduling platform to its cochlear implant clinic partners. Everseat is a dynamic waitlist that helps improve customer experience by helping organizations and consumers book last minute appointments through an easy-to-use mobile app.
“Financial challenges, as well as communication and efficiency challenges, within the healthcare industry have made utilization, efficiency and patient satisfaction top priorities,” said Michele Fusco, Vice President of Market Development at Cochlear. “Recognizing these ongoing challenges, Cochlear has chosen Everseat’s innovative platform to help its clinic partners achieve maximum efficiency, while increasing patient throughput, and ultimately, customer satisfaction.”
More and more patients prefer direct control and contact with their healthcare providers through an electronic platform. In many instances, a lack of transparency around bookings and cancelled appointments means last minute openings are simply unknown, and busy, overwhelmed consumers cannot find the right services at the right time. Everseat’s mobile-ready app allows real-time notification to the patient population for any unclaimed or available appointments.
“We are very pleased to be working with Cochlear and its clinic partners to help streamline the patient appointment process,” said Jeff Peres, Co-Founder and CEO of Everseat. “We are committed to helping bring efficiency to the healthcare community, and we see Cochlear as an innovator and leader in this work.”
About Cochlear Limited (ASX: COH)
Cochlear is the global leader in implantable hearing solutions. The company has a global workforce of 2,700 people and invests more than AUS$100 million a year in research and development. Products include hearing systems for cochlear, bone conduction and acoustic implants.
Over 350,000 people of all ages, across more than 100 countries, now hear because of Cochlear.www.cochlear.com
Everseat is a technology platform that facilitates scheduling between organizations and consumers. Everseat enables organizations to make open appointments available immediately, for same day as well as longer-term appointments. Consumers can quickly and easily find and schedule appointments from the free Everseat mobile app. Last minute availability is posted and claimed in real time, significantly increasing efficiency and profitability while improving consumer satisfaction. For more information, visit Everseat online at www.everseat.com or call 888-899-9506.
# # #